Referanser

1. Ghaneh P, Castello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut 2007;56(8):1134–52
2. Vulfovich M, Rocha-Lima C. Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 2008;8(6):993–1002
3. Strimpakos A, Saif MW, Syrigos KN. Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer Metastasis Rev 2008; 27(3):495–522
4. Michalski CW, Weitz J, Büchler MW. Surgery Insight: surgical management of pancreatic cancer. Nat Clin Pract Oncol 2007;4(9): 526–35
5. Ujiki MB, Talamonti MS. Guidelines for the Surgical Management of Pancreatic Adenocarcinoma. Semin Oncol 2007 Aug;34(4):311–20
6. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg 2004; 91:1410–1427
7. Glanemann M, Baomin S, Liang F, Sun XG, Bahra M, Jacob D, et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? [Online] 2008 [hentet 15 april 2009] Tilgjengelig fra: URL: http://www.wjso.com/content/6/1/123
8. Carpelan-Helström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54: 385–387
9. Westgaard A, Tafjord S, Farstad IN, Cvancorva M, Eide TJ, Mathisen Ø, et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. [Online] 2008 [hentet 15. april 2009] Tilgjengelig fra: URL: http://www.biomedcentral.com/1471-2407/8/5
10. Westgaard A, Larønningen S, Mellem C, Eide TJ, Clausen OPF, Møller B, et al. Are survival predictions reliable? Hospital volume versus standardisation of histopathological reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer 2009, doi: 10.1016/j.ejca.2009.03.019